Latest Derivatives News

Page 35 of 44
Cynata Therapeutics confirms that the recent FDA orphan-drug exclusivity granted to Ryoncil® will not block approval of its CYP-001 therapy, highlighting key differences in drug composition and patient indications.
Ada Torres
Ada Torres
16 May 2025
Metals Australia has successfully produced two commercially viable products from its Manindi Titanium-Vanadium-Iron discovery, while identifying additional promising exploration targets nearby.
Maxwell Dee
Maxwell Dee
16 May 2025
Rhythm Biosciences’ subsidiary Genetype has landed a pivotal 12-month contract with the University of Melbourne to provide advanced breast cancer risk assessments, marking a significant step in personalised cancer screening.
Ada Torres
Ada Torres
15 May 2025
GrainCorp Limited reported a strong first half with revenue up 21% to $4.09 billion and net profit rising 17% to $58.1 million, prompting an increased dividend and share buy-back program.
Ada Torres
Ada Torres
15 May 2025
Euro Manganese Inc. reported a $9.17 million net loss for the six months ending March 31, 2025, while advancing its Chvaletice Manganese Project and pursuing a critical $11.2 million capital raise. The company’s future hinges on successful financing and project milestones amid ongoing development costs.
Maxwell Dee
Maxwell Dee
15 May 2025
Commonwealth Bank of Australia reports a 45 basis point increase in its CET1 capital ratio for Q1 2025, driven by earnings despite rising risk-weighted assets. The bank maintains strong liquidity and leverage ratios above regulatory minimums.
Victor Sage
Victor Sage
14 May 2025
Life360 has reported a landmark first quarter in 2025, with soaring user engagement and robust revenue growth that underscore its resilience in a cautious consumer market.
Sophie Babbage
Sophie Babbage
13 May 2025
North Stawell Minerals has reported promising drill results from its first hole at Darlington West, revealing new Stawell-type gold mineralisation and validating its predictive modelling approach.
Maxwell Dee
Maxwell Dee
13 May 2025
Bio-Gene Technology Limited has launched a Share Purchase Plan allowing Australian shareholders to invest up to $15,000 at 2.3 cents per share, matching a recent $2.1 million placement. The offer includes free-attaching options, subject to shareholder approval, to support key product development milestones.
Ada Torres
Ada Torres
12 May 2025
Victor Group Holdings has established Victor Nexus Pty Ltd to deepen its fintech footprint in Australia and forged a strategic partnership with Shebah, aiming to empower women through innovative financial solutions.
Sophie Babbage
Sophie Babbage
12 May 2025
Horseshoe Metals has extended the gold surface materials processing option at Horseshoe Lights to mid-2025, while advancing copper Direct Shipping Ore activities and negotiating key offtake deals.
Maxwell Dee
Maxwell Dee
12 May 2025
Star Minerals has appointed ResourcesWA to manage the mine approval process for its Tumblegum South Gold Project, setting a clear path to commence mining by Q1 2026 amid strong gold prices.
Maxwell Dee
Maxwell Dee
12 May 2025